Logo | Name | Σ | ||
---|---|---|---|---|
![]() | NHS England We lead and support the NHS in England to deliver improved care for patients. We work with NHS Improvement to act as a single organisation to better support the NHS to deliver improved care for patients: https://www.england.nhs.uk/comment-policy NHS England is increasing transparency in the NHS and improving services for patients. We work with NHS staff, patients, stakeholders and the public to improve the health outcomes for people in England. We are responsible for the stewardship of £99 billion of public funds to provide comprehensive health and care services available to all, where there is clinical need and regardless of an … Sectors: | 690 | 476 | 44 |
![]() | UK Research and Innovation Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves … Sectors: | 2113 | 1601 | 317 |
![]() | Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: | 248 | 89 | 173 |
![]() | Eurasanté Accélérateur des innovations santé-nutrition, bien vieillir en région Hauts-de-France Eurasanté is a regional economic development agency specialized in the the health sector. It supports the different actors dedicated to health related activities with their research, creation and development projects. The Biology, Nutrition and Health Sector of the Nord-Pas-De-Calais represents 800 companies, and 22 000 employees. Located at the heart of a business park of over 300 hectares gathering 7 hospitals, 50 research laboratories, 145 companies, 4 universities, 5 specialized training institutes, it constitutes a unique business environment in the largest university-hospital campus over Europe. 3 kinds of services are part … Sectors: | 347 | 185 | 186 |